These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11140806)

  • 1. Women's health issues in a dialysis population.
    Rush H; Neugarten J; Coco M
    Clin Nephrol; 2000 Dec; 54(6):455-62. PubMed ID: 11140806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider management of menopause after the findings of the Women's Health Initiative.
    Rolnick SJ; Jackson J; Kopher R; Defor TA
    Menopause; 2007; 14(3 Pt 1):441-9. PubMed ID: 17318028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health, preventive health care, and health care access among women with disabilities in the 1994-1995 National Health Interview Survey, Supplement on Disability.
    Chevarley FM; Thierry JM; Gill CJ; Ryerson AB; Nosek MA
    Womens Health Issues; 2006; 16(6):297-312. PubMed ID: 17188213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's preventive screening in rural health clinics.
    Edwards JB; Tudiver F
    Womens Health Issues; 2008; 18(3):155-66. PubMed ID: 18457753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone therapy and the medical encounter: a qualitative analysis of women's experiences.
    Hyde A; Nee J; Drennan J; Butler M; Howlett E
    Menopause; 2010 Mar; 17(2):344-50. PubMed ID: 20124923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion of innovation in women's health care delivery: the Department of Veterans Affairs' adoption of women's health clinics.
    Yano EM; Goldzweig C; Canelo I; Washington DL
    Womens Health Issues; 2006; 16(5):226-35. PubMed ID: 17055375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older women's health priorities and perceptions of care delivery: results of the WOW health survey.
    Tannenbaum C; Mayo N; Ducharme F
    CMAJ; 2005 Jul; 173(2):153-9. PubMed ID: 16027431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VA emergency health care for women: condition--critical or stable?
    Washington DL; Yano EM; Goldzweig C; Simon B
    Womens Health Issues; 2006; 16(3):133-8. PubMed ID: 16765289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why menopausal women do not want to take hormone replacement therapy.
    Rabin DS; Cipparrone N; Linn ES; Moen M
    Menopause; 1999; 6(1):61-7. PubMed ID: 10100182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do socioeconomic gradients in women's health widen over time and with age?
    Mishra GD; Ball K; Dobson AJ; Byles JE
    Soc Sci Med; 2004 May; 58(9):1585-95. PubMed ID: 14990361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study.
    Kramer HM; Curhan GC; Singh A;
    Am J Kidney Dis; 2003 Mar; 41(3):643-50. PubMed ID: 12612988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.